HighTower Advisors
DXCM icon

HighTower Advisors’s DexCom DXCM Stock Holding History

HighTower Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100
Closed -$268 – 3711
2023
Q4 		$268 Buy
+100
New +$10.2K ﹤0.01% 3593
2021
Q1 		– Sell
-8
Closed -$1K – 3104
2020
Q4 		$1K Buy
+8
New +$714 ﹤0.01% 2574
2020
Q3 		– Sell
-800
Closed -$1K – 2583
2020
Q2 		$1K Buy
+800
New +$71.6K ﹤0.01% 2404

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HighTower Advisors's DXCM Position: Q2 2026 in Review

HighTower Advisors reduced its DexCom (DXCM) stake by 9.7% in Q2 2026, selling an estimated $765K and leaving 106,580 shares worth $7.18M. The position accounts for 0.01% of the portfolio, ranked #1061.

HighTower Advisors first reported a position in DXCM in Q4 2014 and has held it in 47 quarters since. The position peaked at $18.5M in Q4 2020. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • HighTower Advisors held 106,580 shares of DexCom worth $7.18M as of Q2 2026.
  • HighTower Advisors sold 11,484 DexCom shares in Q2 2026, an estimated $765K.
  • DexCom made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #1061 holding.
  • HighTower Advisors first reported a position in DexCom in Q4 2014 and has held it in 47 quarters since.
  • HighTower Advisors's DexCom position peaked at $18.5M in Q4 2020.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.